Re9lstered number: OB229467
Ch•rlty numbèr: 1152591
HAEUK
(A company limiled by guarantee)
UNAUDrrED
TRUSTEES. REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025

HAEUK
(A Com￿nY Ilmited by guarantee)
COMTENTS
Page
Ref•rene• and ¥dmlnSstratl¥• dètalls ol the eomp•ny. tts Tnwleeg and advlsers
Tru•tees' report
Indeptrndent e¥•mln•r's report
Slalem•nt of flnancl•l tttlvltles
8018nce sh•èt
Noi•x io the fln•nclal ¥tst•m•nt•
10-20

HAEUK
IA ¢ompany limiled by guarantee)
REFERENCE AND ADMINISTRATIVE DETAILS OF THE COMPANY, ITS TRUSTEES AND ADVISERS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
Trustees
Ann Marie Harding, Chair
Rosemary Frances Joseph. Treasurer
June Cole, Trustee
Dr Timoihy Cfouch, Twslee
Barrie Sidney Hurley. Trustee
Simon Jererny Mumford. Trustee Iiesioned 16 May 20251
Padrnalal Gurugama (appointed 4 June 20251
Arnar QLJreshi lawinted 9 June 20251
Dana Shapiro, Trustee
Company registered number
08229467
Chorlty reglstered number
1152591
Accountants
GhABG LLP
Chartered Tax Advisers and Afthuntants
arine House
151 Western Road
Haywafds Healh
Wesl Sus58X
RH163LH
Page 1

HAEUK
IA ¢ompany limited by guarantee)
TRUSTEES. REPORT
FOR THE YEAR ENDED 30 SEPTEMBER 2025
The Truslees presenl their annual report logether with the financial slalements ol the company for the period 1
Oclober 2024 to 30 Seplefflber 2025. The Annual report serves the purposes DI both a Trustees. rep)rt and a
directors. report uader cotnpany law. The Trustees confirm Ihal the Annual reporl and financial slalernents ol the
charitable ¢ompany cOM￿Y with the current slalulory requirements. the reouirements of the charitable companys
governing documenl and the piovisions of Ihe Statement of Recotnrnended Practice ISORPI applicable 10
charitie5 preparing their aiLount5 In a¢cordance with Ihe Financial Reporting Standard applicable in the UK and
Repuwic ol Ireland IFRS1021 lellective 1 January 20191.
Since the company qualrfies as sm*1 undei section 382 of the Companies Acl 2006, the Straiegic report
required of mediLJm and large ¢offlpanies vrthr the Cornpanies Act 2006 IStrategi¢ Rerx)rt and Directors,
Fleportl Regulations 2013 has been omitted.
Oblecttves and activltles
a. Pollcles and obleetives
The main purpose (>f Ihe charity is lo promote and protect the physical and mental health ol suffer8r5 of
Hereditary Angioedema in the Uniterj Kingdotn Ihrough the provision ol stspport, education practical advice
and lo advance the education of the general public In all areas of the condition.
In settiw objectives aFyJ plaming for actwrfies. Ihe Trustees have given ¢Jue consideralion lo general gUIdar￿
published by the Charily Commission felating to public benefit. including Ihe gu￿ar￿e 'Public benefit. running a
charity IPB21'.
b. Actlvlties undertaken to aehleve oblectlve¥
HAEUK has identif￿d the following a¢livilies to promole the achievemeNt of it5 objectives-
To ensure the UK has Ihe highesl possible starKlards ol treatment loi HAE
To provide patient advocacy and support. aTranging pen(Klic Palient Meetings, and maintaining and
enhancing ihe website.
To make representations on variou5 NHS consuiiation processes and to medical rxolessionals and Iheir
proles510nal bodies.
To commission the production and disseminaiion ol best practice documentation for the rnanagernent of
HAE
Page 2

HAEUK
IA eompny Ibmiled by guar3nleè)
TRUSTEES. AEPORT (COP￿INUED>
FOR THE YEAR ENDED 30 SEPTEMBER 2025
Achievements a￿1 perfornwnce
a. Revlew of actsvltles
2025 was a year of new developffients In the trealment aThY managetnent ot HAE wth a number of products
goirKJ through clinical ITial arKI then the MHRA 3￿j NICE approval process. A long journey but wth one new
treatment now approveo Iiy use in Ihe NHS. several more are In the latter slage arKI the choices for patients
Continues to grow arKI improve.
The CEO wa5 involved in a large number ol meetirKJs thro￿ghoUl Ihe l&si linanoal year In I￿ak￿ng
representations on beham of the patsent cotnmuruty. IcNJelher with gNiTrJ ewxrt a(ffte alongside several of the
Trusle85.
The Shared Decision Makiw "Power of Partrwship- Fyogramme lunded by Biocryst was a huge succes5 and
nearly all Clin￿13￿5 in the UK rK)w adopt a very p)SitNe a￿knIe io wothing jointly wth patients, enablirMJ patients
themselves lo also feel m￿e Involv&1 wt)en mak¢ng ch9￿e5 abo(rt treattnent5.
The CEO ￿s0 att&Kkd the Immunokw athy Allergy Nurses Gffjup in Bimiiryham. Visiled several dinics. visited
offices ol some of the pharma¢wlKal companEs and had many Mee￿.r￿jS wth the cl1r71c￿ Reference Group lor
mMU¥￿10gY and Allergy. ￿1￿ Genetic Alliarte arKI Rafe Disease UK.
In athjition. the CEO and Sever￿ T¥ustees atte￿e￿ the HAEi ConfeTerrE in Copenhagen. the Rare Disease Day
event organised by Genetic Aliance ai ihe House of Commons. arKI the European Associabon of Allergy ancl
Cl+nvl Imm(&nolooy annual conleier*e in GlaS(￿w.
b. Fundralslng acti¥il•es and Income generallon
The wimary swrce of Ir￿Me remains donations from pharMa￿ul$cal companies fdlowng Submission ol the
necessary iMJs*ness ￿arts lo them. Other lurKJiry irKludes FouTrJabon ￿ mernbers fyrKlrai5ing events.
Flnanelal rev
. Golng ¢oncern
Alter makiNJ aFpTopriate eryujries. the Trustees have a reas(￿ble expeclation that the wfflpany has adequate
re50urGe5 to continue In operabon& exisience lot ihe foreseeabk luture. For thi5 ￿aSon. they continue to adopt
the g(MW cOr￿ern ba5LS in preparir*J Ihe Iinanr3al siatefflents.
b. Atserves poll¢y
It is the polw ol Ihe Tr4Jslees to In￿rrta¢￿ a W of reseThes wfficient to cover 3 months anticipate
exwxlrture At XJ September 2025 the of reserves was consisieth this ￿lley.
e. Prlnelpal lundlng
Donahons from pharmaCthrt￿ companies femairs the wimary source of fufKIl￿. However have secured
addilional funding from a FoLtndaiion Trusi.
Page 3

HAEUK
IA eompany limited by g￿rantee
TRUSTEES. REPORT ICONTINUEDI
FOA THE YEAR ENDED 30 SEPTEMBER 2025
Structure, go¥emanc• and management
a. Constltulion
HAEUK is registered as a chan.lth wpaFry limrted ty ￿larantee arKI was sel tsp by a Memorandum of
Asswaiion.
11 is exempt from the use ol Ihe *r￿d.1￿￿1t￿I'.
b. M￿h0o$ of appolntmènt or electk>n ot Trustees
The management ol the company is Ihe resp*￿￿￿)￿AY ol Ihe Trustees w￿1 are el￿ted arKI eo.opled UFKler the
terms of the Articles ol AsSocia￿n_
Plans tor future perlods
HAEUK wll conknnue to er￿Urage paiBIts aThl ihe ¥TrJer to fuThyr￿S¢ VJ, by way ol donations,
Sp￿sOrshIp, a￿¢ wUlarIpa￿￿l giviThJ tn uder to t￿defi the scoFe of rt5 lurmliwy sources.
HAEUK I￿11 to umlate,'wcxJuce a fange ot pdoes to ￿mIa￿ze ts cperatiTrJ arrarvJements etc." iogeiher wlh
developing a secuie data slorageifiling system.
A cofflprehensNe utxlale ol its website be lina1￿&1, wc**irKJ lovrdrd5 a s￿11￿ memberfs only
section.
HAEUK wll aim to more ￿ Ihe nèuls of cliikjren armj ￿)Ur￿ peoF4e ￿ envsage that vrlunleers wll play
an irtreasing iole in Ihis ￿￿e$s.
HAEUK is proposiw to exterky its InflUer￿ arKI 5UFrAyt to patients in other parts ol lh8 Unite(l Kinodom.
The trustees wll keep HAEUK'5 5 Year strateg￿ Plan uw¥Jer revivw artl ￿%￿at￿l.
Members. liabillty
The MemtErs of the Company ￿aran￿e ￿ conthtmfie an amounl not e¥ceed¢ng £1 10 the assels of Ihe cornpany
In the event of ￿r￿￿"r￿ up.
Page 4

IA company limited by guaranleel
TRUSTEES. REPORT ICONTINUEDI
FOR THE YEAR ENDEO 30 SEPTEMBEA 2025
Statemènt of Trustees, rè3ponslbi1lt￿S
The Truslees (who are also I*E (hrectors of ts ￿rnpanY tot Ihe purty)5es of company lawl are responsible lor
preparing the Tru5tees' rewxl arKJ the finarvJ stalemenls in a￿rdafice with applicable law and United
Kingth)m Accounting Stawxlards Iunrfed ￿n9th)m Ge￿r￿lY Accerl* AccounliTYJ Pockel.
Company law r￿j•re$ the Trustees to ￿e￿are linawKial stat8ment5 IOT each linaTh)al . Under company law. the
Trustees ￿ust nol approve the finalLI￿ statemenls unless they are sab'sfied that Ihey give a iiue and fair view of
Ihe slate of affairs ol the company and of lis i￿￿￿11¥j resources arKJ aFVtcaiion of resources, in¢ludirKJ its
inctsme and eX￿￿litUre, for thal PEfK)d. In preparry these linar￿la1 statemefits. Ihe Trustees are required lo:
seleGI suit*Je accounting polices ar* lh￿ them corLSiStently,'
observe the melhocls and principles of Ihe Charities SORP IFRS 1021-
tnake iudgments al￿ accounting estirFFale5 ihal are reasonable and FKtheni".
state vthether aFOicatde UK Accwnting StaThYards IFRS 1021 have been followed. subj'ttt io any matÈrkHI
departures d15cthed a￿1 explaine(J In the ftnancial stalemenls..
prepare the linancial statements on the g)ing cLrtem basis un*ss rt is inappropriate to presume that Ihe
comparty ￿11 cot)Iinue in business.
The Tru5tee5 are re¥Xjn5i￿e for keeyw adequate a(xountiThJ records that are to show armj explain
Ihe compary's transauions aré disclose with reasonthe accuracy at any lime the finartial wsrtion ol the
company enable them lo ensure thal the finanuaj statemenls comply wth 11)e Companies Act 2006. They
are also resFx>nsibl8 lor safeguardng the assets of Ihe company a¥MJ herte lor takiw reason*e steps lor Ihe
prevention ￿ delecb¢Jn ol IraL#Y aTrY other KrgJuLaiilies.
Approved by ordw of the members of Ihe troard of Trustees on Apr 28. 2026
behaL+ by..
a￿1 ￿ne￿ on their
Ann Marre Harding
(Chair of Trusteesl
Page 5

HAguK
(A cornpany Ilmlted by guarantee)
INDEPENDENT EXAMINER'S REPORT
FOR THE YEAR ENDEO 30 SEPTEMBER 2025
Independent examlner'$ report to the Trusleos ol {'the company.)
I report to the charity Twste8s on my examination ol the ac¢ounls ol the Company lor the year ended 30
Seplember 2025.
R8sponslbllltle¥ and basls of report
As the Trustees ol the company land its directors lor tho purposes ol company lawl you are responsible lor the
preparation ol the accounts in aecordan¢e with the requirements ol the Companies Act 20061.ihe 2006 Acl'l.
aving salislied mysell that the accounts ol the company are not required to be audited under Pan 16 01 the
2006 Aci and are eligible loi independenl examinaiion, I feport in respect ol my examination ol the company's
accounts carried out under section 145 01 the Charities Act 2011 Ilhe 2011 Acl'l. In carrying out my examination
I have lollowe(I the Directions given by tho Charity Commission undor section 1451511bl ol the 2011 A¢1.
Independent examlner's slalernent
I have completed my èxamination. I conlirm that no matters have comè to my atteniion in ¢onneclion wilh Ihe
examination giving me cause lo believe..
accounting iecords were not kept in respecl ol ihe company as required by section 386 01 the 2006 Aci.,
of
the accounts do not accord with those records.. or
the accounts do not comply wilh the accounting requirements ol seciion 396 01 the 2006 Act other than
any requiremeni thai thè accounts give a 'iruo and lair, view which is noi a mailer considered a$ part ol
an independent exarninalion.. or
the accounts have not been prepared in accofdanee with the melh&Js and principles ol the Sialemeni ol
Recommended Practice lor a¢coufiling and reporting by charities lapplicable to charilie5 preparing Iheir
accounls in accordance with ltte Financial Reporting Standard applicabl8 in the UK and Republic ol
Ireland IFRS 10211.
I have no concems and have come across no other rnatters In conneciioft with the examination lo which
attention should be drawn in this report In order lo enable a proper understanding ol the accounts lo be reached.
This report is made solgly lo the companys Trustees. as a body, in accordance Trmth Part 4 01 the Charities
IAccounis and Reportsl Regulations 2008. My work has been undenaken so that I might Slal8 lo the company's
Trustees Ihose matters l am required lo siaie to Ihem in an Independent examinerfs report and lor no other
purpose. To the fullest extenl permitted by law. I do not accepi or assume responsibilily lo anyone other than the
company arid Ihg company's Trustees as a bcwjy, lor my wo(k oc lor this reFQrt.
Signed..
Graham Hole
gr￿kn￿
Daled..
28 April 2026
GMBC LLP
Chartered Tax Advisers and Aecounianls
Marine House
151 Western Road
Haywards Heath
West Sussex
RH16 3LH
Page

HAEUK
IA company limited by guarantee}
ST ATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNTI
FOR THE YEAR ENDED 30 SEPTEMBER 2025
Unrestrlcted
lunds
2025
Total
fund¥
2025
Total
lunds
2024
Notè
Income from-
Donalions atKI lega¢ies
102,670
102,670
73, 100
Totsl income
102,670
102,670
73, 100
Expenditure on:
Charilable activities
120.280
120,280
129,363
Total •xpendSture
120,280
120,280
729,363
Net moveTnent in funds
{17,610}
{17,6101
(56,263)
Reconclllatk)n of funds=
Tolal fullds broLJghl Iofward
Net tnovetnent In funds
122,291
{17,6101
122,291
117,6101
178,554
(56,263)
Totsl lunds forward
104,681
104,681
122,291
The Statement of financial activities includes all gains and losses recognised in the year.
The notes gn pages 10 10 20 fortn part ol these tinancial statements.
Page 7

HAEUK
IA company Ilmlted by guarantee)
REGISTERED NUMBER: 08229467
BALANCE SHEET
AS AT 30 SEPTEMBER 2025
2025
2024
Note
Fixed assèts
Tawble assets
2,231
2,231
Current assèts
Cash at bank ar¥1 in ha￿1
lo9￿35
125,604
109535
125,604
Current liabilities
Credilors.. arnounts falh"rMJ thje wnthin or
year
{6.6381
15,544)
Nel current asset#
102,897
120,060
Total assets less ￿rren1 liabilities
104.681
122,291
Total nel assets
104,681
122,297
Ch8riiy lunds
Reslricled lurKIs
Unrestricted
104,681
122.291
TGtal funds
104,681
122.291
Page 8

IA company limlted by guarantee)
REGISTERED NUklBER.. 08229467
BALANCE SHEET ICONTINUEDI
AS AT 30 SEPTEMBER 2025
The company was entilled to exemption from audit sedion 477 of the Companies Act 2006.
The memters have not required the company to obtain an audbt lof the year in question in accordance with
seclK>n 476 01 Companies Act 2006.
The Trustees acknowledge their responsib'lities for cOrnpl￿ng swlh the requirements of the Act with respect 10
accounting records and preparaiK)n of financial statements.
The tinancial statetll8nts have been prepared in accordance with the pfovisions atplicatAe lo entilies Su￿ect to
the small companies regime.
The linanaal
statetnents
wefe
?￿￿ 2026
approved
aLrthorised for
issu8
by the Truslees
arKI s￿ned on their behalf by."
Ann Marie Hardlng
(Ghair ot Trusleesl
The notes on page5 10 to 20 form part ol these financial statements.
Page 9

HAEUK
{A eomp•Try limited by guaranlee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
General Inforniatlon
HAEUK Is a private company. limilecl by guararrtee. doM￿l￿d in England and Wales. regislration number
08229467. The registered charity number is 1152591. The registered orfice of the company Is 2 Sheridan
Close. Bndgwater, Sornerset. TA6 SSN.
Accounting policies
2.1 Basls of PTeparatlon ol flnanclal statements
The financi& slalements have been prepargj In accordance with the Charities SORP IFRS 1021-
Accounting Rewrting by Charilies." Stalemenl of Recommended Practice apJicable lo charities
preparing th￿r accounts Irh accordance with Ihe FinatKial Re[M)rtI￿ Standard applicable in the UK
ano Reputlic of Ireland IFRS 1021 leffective 1 January 20191. the Financial Reporting Standard
appli￿ In the UK and Republic of Irelar¥J IFRS 1021 arwj the Companies Aci 2006.
HAEUK meets the definition of a putAr be￿trt ￿litY V￿ler FRS 102. Assets ar￿ lsabiltties are initial
recogrnsed at histortd CO￿ or iran&iction v¥ue unks5 Otherwse slal&Y in Ihe rgkvant accounliNJ
poly.
2.2 Income
Ir*come is rec(wtsed the company has enithment to the I￿￿)Me. rt is probable that the
Ir￿orne wll be recewed arml the amount of wwme receiv*Ae can t* measured reliabty.
2.3 Expenditure
ExperKliliJre is reCogn￿ed once Ihere is a legal or consiruthNe otAwJation to transfer economic benefil
to a Ihird party. rt Is probable Ihat a transler of ecorK)mK benefits wlll be required ITr settlemeni aThJ
the amoijnt of the obligation can tye measured reliably.
Expendilure s arLounted for on an awwals basis arKI has tMn Ind￿￿ed L%TrJer expense cèlegoriès
that a￿regate all costs for ￿l(￿￿10n io actI￿ties.
Expendilure on charilable aclmties is i￿Urred on direciiy urKlertaking ttE activitlg5 which further Ihe
company s objectNes. as well as any assoTrat•Y suFwt cosls.
All eXpeThjilu￿ is itluswe of ivrecoverable VAT.
Page 10

HAEUK
{A company limited by guaranteè)
NOTES TO THE FIPIANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
Accounling policies Icontinwll
2.4 Tangible Ilxed assets arKI I￿PreCiatIon
Tangl￿e fixed assets costiThJ £10) w more are carAtalised arKJ recognisaj when luture ecorbomic
benefrts are wobaNe arxl ihe cost or vdue ol tr￿ assel can tre measured rel￿￿y.
Tangl￿e fixed assets are Initialty fec(wJn15ed at C05t. After recognition. UE*er Ihe cosl model, tangible
lixed a5se15 are measvred al ￿51 le55 accufflulaled depreciation and any acGumulated Impairmerrt
losses. All costs incurre(I to bring a tsTu"tle fixed asset inio Ils interKJed wothing coThJition should be
ificluded in Ihe measkjremeni of cosi.
Depreciation is charged so as lo all¢xate the wst of I￿1)1? fixaj assets less Iheir resldual value
¢)ver their estimated useful lryes. on a reducsrMJ b￿ance bags
Oepreciaiion is wovKl&J ￿ the fdbw"r•J bas￿.
Othce equiwe
2.5 Cash at bank and in hand
Cash al bank ar￿ in harKJ includes cash aFKJ short-tenn tt#Jhly I#>J￿ irwesffiients with a 5h¢yt malurity
ol three tnonths (x ￿$S IrLMn the dale of acojiglion or orpn4ng ol tt)e deposit or similar account.
2.6 Liabilttle¥ and provislon8
Lfrkn"lrties are reuNJntsed when Ihere an at Ihe BaLa￿e she8t date as a resutt of a past
eveni. rt is prOba￿e that a Iransler ol econom￿ ￿nefit wll be required in sethement. a￿1 the amounl
of the settlemenl can be estimated ￿l&ly.
Liats"libes are rec(MJnssÈd at the amount that the company antKJpaies It wll pay to selllÈ ts dgbt
the amoLJnt it ha5 recewed as atha￿) paymenis IC￿ the 01 servw it must prowde.
Prowsions are measur•J at the estimate ol the amounis r&]uired to settle the obligation. Where
the eftect of the tirne value of morey L8 material. the w0vis￿ is based on the present value of those
amounts, &scounied at the we-tax th"scouni raie thai rellects the risks specific to the liability. The
unwindiro of the discount is re(xwI￿a in the Slalernent ol tinarKial activthes as a tinance cost.
Page11

HAEUK
IA cOmp￿Y limlltd by gu•rnnteel
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30SEPTEMBER 2025
Aceountlng polbclèx Icontlnutdl
2.7 Flnancl•l I￿1￿Ment5
The company On￿ has I￿arK*a1 assels aTh1 finart￿l liablilbes of a kirKI thai qlbalrfy as ba$1¢ financial
in5trurnenls Bas￿ financial Inslruments are inibalty recogniseLI al tTansactK)n v&ue subsequenlly
measured at thwr seluement Val￿ ￿th Ihe exceplK)n ol bank loans which are subsequenlly
mgasured at amortt50d cosl Ihe elfecXNo interest method.
2.8 Fund •ceountlng
G¢nèral funds Unrestr￿6￿ fun(Is a￿ available lor use at tha discretion ol the Trustees in
lurtherance ol the general C*4e¢t1v￿ of t￿ ccrfnpany athj which have nol bgen d￿￿d￿al￿d lof Olher
PUfrAJse5.
Page 12

HAEUK
IA company lim￿ed by guarantee)
NOTES TO THE FIP4ANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
Unrestrl¢t
tuTh1s
2025
Total
lunds
2025
Tolal
funds
2024
Donatlon*
CSL Behiing
The Anderson FourKlation
Kalvisia PharmaceutuLs
HAE International
Biocrysl Phafmaceulrds
UThversity Hosprfal Bwrnryharn
30.375
16,5
iO.OLKJ
32,285
10,6
30.375
16.5fy)
10.
32.285
10,6fy)
16.500
17,428
20. 150
13.030
Sublotsl d•l•llpd dl•clowro
99.780
99.760
67, 108
Donatlons
2,910
2.910
5,992
Sublot•l
2,910
2.910
5,992
Toi•l 2025
102.670
102,670
73, 100
Total 2024
73. 100
73, 100
P￿13

HAEUK
(A company limlted by guarantee)
P40TES TO THE FINANCIAL STATEIAEPffS
FOFI THE YEAR ENDED 30 SEPTEMBER 2025
Analysis of expendlture ¢)n ¢haritable activitles
Summary by lund type
lutKIs
2025
Tolal
2025
Total
2024
SLtw)rt and educatKm to hety) sufferers ol H8redrtary
AThJoedema In the UK
120,280
120.2
129.363
Tota12024
129.363
129,363
Anatysis of expendilure by acilvllles
Acllvftles
undertaken
dlre¢tly
21r25
Support
coJ15
Total
tunds
2025
Total
funds
2024
2025
Support and education to he￿) Sulle￿rS ol
Hereclrtary Aw)&Yema in the UK
32.857
87.622
120.279
129.363
Total 2024
39.2C6
90, 157
129.363
Page 14

HAEUK
IA company limited by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
Analysls of expendllure by actiyitoes {eoThtlnu8dl
Anolysls of dirtd costs
Tolal
fund5
2025
Tolal
funds
2024
Aeiivltles
2025
Pathenl suivey cosis
Virlual patient days
Research into the INed eXper*r￿ of Herajrtary Ar¥j￿Ma
Costs of activity-CafflpawJn cost
Other
5.919
5,919
1,892
28,738
26,739
26,739
{1)
To¢al 2025
32.657
32.657
39.206
Total 2024
39.206
39.206
Pag8 15

HAEUK
IA company Ilmlled by guaranteè}
NOTES TO THE FINANCIAL ST ATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
AnalysSs ol expendKure by a¢tivilie¥ Iconllnuedl
Anatysis ol support cos1¥
Totsi
funds
2025
Tora
funds
2024
Actlvities
2025
Depreciation
Communication costs
Websile costs
Postage. priniing and stationery
Travel and subsistence
Trwning & Seminar
Subscription costs
CEO consultancy fees
EO oonsullancy lees
sUr￿ry expense5
Advertising & markgting ¢QSt
Insurance
Accountarw fees
Film produc150n
IT software and consumables
Design services
446
431
558
431
2.118
2,118
5,Q46
2.713
8,684
772
4.B13
466
4,B13
466
Y.489
36,575
15, 180
316
45.380
14,855
524
45,380
14,855
524
14.644
201
14.644
201
1.302
1.302
1,421
16,605
971
820
50
820
Total 2025
87.622
87,622
90, 157
Total 2(124
90. 157
90. 157
Independeni examiner'$ rèmuneratlon
2025
2024
Fees payable to the company's independent examiner lor the independenl
examination of Ihe ¢ompany'5 annual accoun15
Fees payable to th8 company's independeni examiner in reswl of..
All other services not included above
318
Page 16

HAEUK
IA company Ilmiied by guarantee)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30SEPTEMBER 2025
Trustees. remuneration and expense$
During the year. ￿ Trustees received any rernunerab.on or other benefits (2024 - £NIL?.
During Ihe year ended 30 Seplembei 2025. expenses iolalliog £1.260 were reimbursed or paid directly to
3 Tiuslees. The ex￿n5￿$ felated io travel cost and HAE suNey cost.
Tangible fixed assets
Offlce
equlpment
Cost or valuatioft
At l October 2024
,711
At 30 Seplefflber 2025
8,711
Depreciation
Al l October 2024
Charge for the year
6,480
446
At 30 Swember 2025
6,926
Net book value
At 30 Sepiember 2025
1.785
At 30 Swember2024
2,230
Page17

HAEUK
(A conyAny limited by guoranteel
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30SEPTEMBER 2025
Credltors: Amounts f•lling due wlthln OM year
2025
2024
Accru￿5 arKI delerred irthme
5.544
10.
Flnaneial instruments
2025
2024
Financial assets
Finanoal assets measured at amortised cx)51
109,535
125,604
2025
2024
Financial liabilltles
Financ￿ l*ililies mea9Jr￿j at am(v1iswJ cost
{6.6381
{5,5441
Financial assets measured at aM￿￿Se￿ cosi ci)mw"ses cash at bank a￿1 in hand.
Financial liatslities measured at amortis￿l cost 0)mpr￿S aczruajs.
Page 18

HAEUK
(A comp•ny limiled by gwr•nie¢l
NOTES TO THE FINANCIAL ST ATEMENTS
FOR THE YEAR ENDEO 30 SEPTEMBER 2025
Stalement of lunds
Slal•ment of tunds- current year
Balance at
30
Soptèmber
2025
B•lpnce •t 1
October
2024
IneoTh ExpenOllur•
Vnrtstri¢t￿ lund•
Ge￿ra1 . all luThls
122.291
102,670
{120.2801
104.681
Sl•tement of lund*- prfor y••r
Balance al
30
Septernb
2024
8alarte ai
l (￿lotsel
2023
I￿orne Exponthtur8
Unrestrtet•d funds
General Fu￿3 . all luThJs
778.554
73, yLiI
(129,363)
122,291
Page19

HAEUK
IA compgny lirnited by guarnniÈÈ)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
12.
Analysis of net assets between funds
Anatysls 01 net assets between funds. curyenl year
Unrestricted
lunds
2025
Total
lunds
2025
TangibTe lixed assèts
Current as5eEs
C¥edrtors due ￿thIft ￿e year
1.784
1,784
109.535
16.6381
109.535
16.6381
Totsi
104.681
104.681
Analysls of nel assets belween tunds- wlor year
Unreslricted
funds
2024
Totaj
funds
2024
Tangible fixed assets
Currenl assets
Creért¢ys due Ynlhin one yeaT
2.231
2.231
125.604
15,544}
125.604
15.5441
Totsl
122,291
122,291
Page 20